ANGPT2 and Sturge-Weber syndrome: Interestingly, GNAQ mutations drive constitutively active PLCB3 which increases ANGPT2—as a corollary, blocking ANGPT2 normalized enlarged vessels suggesting a potential treatment approach for Sturge-Weber syndrome [261].